Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts
- Authors
- Parka, Yo Seph; Nemeno, Judee Grace E.; Choi, Na Young; Lee, Jeong Ik; Ko, Kisung; Choi, Seung-Cheol; Kim, Wan Seop; Han, Dong Wook; Tapia, Natalia; Ko, Kinarm
- Issue Date
- 3월-2016
- Publisher
- WALTER DE GRUYTER GMBH
- Keywords
- cancer; ectopic overexpression; Nanog; transformation; tumorigenesis
- Citation
- BIOLOGICAL CHEMISTRY, v.397, no.3, pp.249 - 255
- Indexed
- SCIE
SCOPUS
- Journal Title
- BIOLOGICAL CHEMISTRY
- Volume
- 397
- Number
- 3
- Start Page
- 249
- End Page
- 255
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/89391
- DOI
- 10.1515/hsz-2015-0255
- ISSN
- 1431-6730
- Abstract
- Key regulatory genes in pluripotent stem cells are of interest not only as reprogramming factors but also as regulators driving tumorigenesis. Nanog is a transcription factor involved in the maintenance of embryonic stem cells and is one of the reprogramming factors along with Oct4, Sox2, and Lin28. Nanog expression has been detected in different types of tumors, and its expression is a poor prognosis for cancer patients. However, there is no clear evidence that Nanog is functionally involved in tumorigenesis. In this study, we induced overexpression of Nanog in mouse embryonic fibroblast cells and subsequently assessed their morphological changes, proliferation rate, and tumor formation ability. We found that Nanog overexpression induced immortalization of mouse embryonic fibroblast cells (MEFs) and increased their proliferation rate in vitro. We also found that formation of tumors after subcutaneous injection of retroviral-Nanog infected MEFs (N-MEFs) into athymic mouse. Cancer-related genes such as Bmi1 were expressed at high levels in N-MEFs. Hence, our results demonstrate that Nanog is able to transform normal somatic cells into tumor cells.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.